Embargoed Release: 10:15hrs, 29 June 2007
SOPHEON PLC
("Sopheon")
DIRECTORS' SHAREHOLDINGS
Sopheon plc announces that it has granted options over Sopheon Ordinary Shares
to certain directors as part of a grant of options to management and staff of
the group. The options have been granted at a price of 19p per share, being the
closing price on 28 June 2007. As part of this overall grant, Barry Mence,
Andrew Michuda and Arif Karimjee, being respectively Sopheon's Chairman, CEO
and CFO, have been granted options over 100,000, 250,000 and 100,000 ordinary
shares respectively. Vesting of half of the options granted are subject to
performance conditions based on the achievement of certain financial objectives
in 2007.
For further information contact:
Barry Mence, Chairman Sopheon plc Tel : +44 (0) 1483 685 735
Arif Karimjee, CFO
Sarah Wharry, Nominated Seymour Pierce Limited Tel: +44 (0) 207 107 8000
Adviser
Andrew Tan Hansard Group Tel : +44 (0) 207 245 1100
Floor van Maaren Citigate First Tel : +31 (0) 205 754 010
Financial
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.